HYALO4 Line

HYALO4 Start

Hyaluronic acid sodium salt (0.2%) and Collagenase collagenase from Vibrio alginolyticus (not less than 2.0 nkat/g of ointment)

HYALO4 Plus

Hyaluronic acid sodium salt (0.2%) and Silver sulfadiazine (1%)

HYALO4 Control Spray

Hyaluronic acid, sodium salt (0.2%) and Metallic silver (2.0%)

HYALO4 Regen

Sodium hyaluronate 2.5% + Horse collagen 97.5%

HYALO4 Skin

Hyaluronic acid sodium salt 0.2%

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.